Casey Lynch, CEO of Cortexyme, to Speak at Silicon Valley Bank Healthcare Connect

By June 8, 2016 May 3rd, 2019 No Comments

Cortexyme, Inc., a company developing novel disease modifying therapeutics for Alzheimer’s and other degenerative disorders  today announced it will participate in the 4th Annual Silicon Valley Bank & DLA Piper Healthcare Connect 2016 conference, in Sonoma, California June 9-10, 2016.

Casey Lynch, co-founder and CEO of Cortexyme, will provide an update on the company’s recent financing and product development progress at 11 a.m.  on Friday June 10.

Healthcare Connect is a gathering of strategic investors and select CEO’s in Napa Valley California.

About Cortexyme

Cortexyme is a private company based in South San Francisco, California developing therapeutics to alter the course of neurodegenerative and other disorders. Cortexyme is targeting a specific, undisclosed infectious pathogen tied to neurodegeneration in humans and animal models.  Proprietary small molecules are currently in preclinical testing. For more information on Cortexyme, visit